This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Dermatol. 1998;134:1049-1050.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE fluoroquinolones ciprofloxacin and ofloxacin are among the antimicrobials recommended for treating uncomplicated gonorrhea.¹ Fluoroquinolone-resistant strains of Neisseria gonorrhoeae have been identified frequently during the 1990s in the Far East.² In the United States, fluoroquinolone-resistant N gonorrhoeae has been reported sporadically; resistance associated with clinical treatment failure has been reported previously in only one person, who probably acquired the infection in the Philippines.^3-5 This report describes the results of an investigation in 1997 of two cases of gonococcal infection in the United States with strains with a higher level of fluoroquinolone resistance than reported previously; clinical treatment failure occurred in one case.

CASE REPORTS

Patient 1

On July 14, a 24-year-old man sought care at the San Diego County Public Health Sexually Transmitted Diseases (STD) clinic following a 2-day history of purulent urethral discharge. Four days before onset of symptoms, he had had vaginal intercourse with a commercial sex worker in San Diego. He . . . [Full Text of this Article]

Patient 2

FOLLOW-UP INVESTIGATION

Reported by:

Editorial Note:


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?